UCLA physicians have pointed out that the common risk of significant weight loss on GLP-1 drugs is being accompanied by sarcopenia, which can cause long-term negative health implications, such as increased fracture risk, decreased mobility, lowered metabolism, and reduced quality of life
Regulatory status: Melanotan II is not approved by the FDA for human use and is not available for human consumption
Combined with diagnostic testing that reveals your biological age markers, these protocols are designed to slow the cellular mechanisms of aging and support long-term vitality
For more persistent reflux, your GP may recommend: Proton pump inhibitors (PPIs) such as omeprazole or lansoprazole, which reduce stomach acid production and are the first-line treatment for GORD according to NICE guidance, typically for 4-8 weeks with review
If this sounds like you, dont worry
DOI Citations are provided for education only